<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35415310</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2452-199X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>18</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Bioactive materials</Title>
          <ISOAbbreviation>Bioact Mater</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Dimethylamino group modified polydopamine nanoparticles with positive charges to scavenge cell-free DNA for rheumatoid arthritis therapy.</ArticleTitle>
        <Pagination>
          <StartPage>409</StartPage>
          <EndPage>420</EndPage>
          <MedlinePgn>409-420</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bioactmat.2022.03.028</ELocationID>
        <Abstract>
          <AbstractText>Excessive cell-free DNA (cfDNA) released by damaged or apoptotic cells can cause inflammation, impacting the progression of rheumatoid arthritis (RA). cfDNA scavengers, such as cationic nanoparticles (NPs), have been demonstrated as an efficient strategy for treating RA. However, most scavengers are limited by unfavorable biocompatibility and poor scavenging efficacy. Herein, by exploiting the favorable biocompatibility, biodegradability and bioadhesion of polydopamine (P), we modified P with dimethylamino groups to form altered charged DPs to bind negatively charged cfDNA for RA therapy. Results showed that DPs endowed with superior binding affinity of cfDNA and little cytotoxicity, which effectively inhibited lipopolysaccharide (LPS) stimulated inflammation <i>in vitro</i>, resulting in the relief of joint swelling, synovial hyperplasia and cartilage destruction in RA rats. Significantly, DPs with higher DS of bis dimethylamino group exhibited higher positive charge density and stronger cfDNA binding affinity, leading to excellent RA therapeutic effect among all of the treated groups, which was even close to normal rats. These finding provides a novel strategy for the treatment of cfDNA-associated diseases.</AbstractText>
          <CopyrightInformation>© 2022 The Authors.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Ying</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Guangxi Engineering Center in Biomedical Materials for Tissue and Organ Regeneration, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Guangxi Collaborative Innovation Center of Regenerative Medicine and Medical Bioresource Development and Application, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Yonglin</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Guangxi Engineering Center in Biomedical Materials for Tissue and Organ Regeneration, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Orthopedics, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Xianfang</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Guangxi Engineering Center in Biomedical Materials for Tissue and Organ Regeneration, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Oral Radiology, College of Stomatology of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cai</LastName>
            <ForeName>Jinhong</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Guangxi Engineering Center in Biomedical Materials for Tissue and Organ Regeneration, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Guangxi Collaborative Innovation Center of Regenerative Medicine and Medical Bioresource Development and Application, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Yuting</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Guangxi Engineering Center in Biomedical Materials for Tissue and Organ Regeneration, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Guangxi Collaborative Innovation Center of Regenerative Medicine and Medical Bioresource Development and Application, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Orthopedics, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Hanji</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Guangxi Engineering Center in Biomedical Materials for Tissue and Organ Regeneration, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Guangxi Collaborative Innovation Center of Regenerative Medicine and Medical Bioresource Development and Application, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Yuan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Guangxi Engineering Center in Biomedical Materials for Tissue and Organ Regeneration, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Guangxi Collaborative Innovation Center of Regenerative Medicine and Medical Bioresource Development and Application, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Orthopedics, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Guangxi Key Laboratory of Regenerative Medicine, International Joint Laboratory on Regeneration of Bone and Soft Tissues, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zheng</LastName>
            <ForeName>Li</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Guangxi Engineering Center in Biomedical Materials for Tissue and Organ Regeneration, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Guangxi Collaborative Innovation Center of Regenerative Medicine and Medical Bioresource Development and Application, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Guangxi Key Laboratory of Regenerative Medicine, International Joint Laboratory on Regeneration of Bone and Soft Tissues, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Jinmin</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Guangxi Engineering Center in Biomedical Materials for Tissue and Organ Regeneration, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Guangxi Collaborative Innovation Center of Regenerative Medicine and Medical Bioresource Development and Application, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Orthopedics, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Guangxi Key Laboratory of Regenerative Medicine, International Joint Laboratory on Regeneration of Bone and Soft Tissues, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gao</LastName>
            <ForeName>Ming</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Guangxi Engineering Center in Biomedical Materials for Tissue and Organ Regeneration, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Guangxi Collaborative Innovation Center of Regenerative Medicine and Medical Bioresource Development and Application, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Bioact Mater</MedlineTA>
        <NlmUniqueID>101685294</NlmUniqueID>
        <ISSNLinking>2452-199X</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cell-free DNA</Keyword>
        <Keyword MajorTopicYN="N">Immunotherapy</Keyword>
        <Keyword MajorTopicYN="N">Nucleic acid binding affinity</Keyword>
        <Keyword MajorTopicYN="N">Polydopamine</Keyword>
        <Keyword MajorTopicYN="N">Rheumatoid arthritis</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflicts of interest were disclosed.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>13</Day>
          <Hour>5</Hour>
          <Minute>36</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35415310</ArticleId>
        <ArticleId IdType="pmc">PMC8968194</ArticleId>
        <ArticleId IdType="doi">10.1016/j.bioactmat.2022.03.028</ArticleId>
        <ArticleId IdType="pii">S2452-199X(22)00143-8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Snyder M., Kircher M., Hill A., Daza R., Shendure J. Cell-free DNA comprises an InVivo nucleosome footprint that informs its tissues-of-origin. Cell. 2016;164:57–68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4715266</ArticleId>
            <ArticleId IdType="pubmed">26771485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heitzer E., Auinger L., Speicher M.R. Cell-free DNA and apoptosis: how dead cells inform about the living. Trends Mol. Med. 2020;26:519–528.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32359482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han D., Lo Y. The nexus of cfDNA and nuclease biology. Trends Genet. 2021;37:758–770.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34006390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hasimoto T., Yoshida K., Hashimoto N., Kaneshiro K., Nakai A., Kawasaki Y., Hashiramoto A. AB0248 circulating cell free DNA; A marker to predict the therapeutic response for biological dmards in rheumatoid arthritis. Ann. Rheum. Dis. 2016;75 983.1-983.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27943573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Antonyan A., Harutyunyan R., Sharoyan S., Karapetyan L., Mardanyan S. AB0032The adenosine deaminase isoforms activity in synovial fluid in patients with different arthritis. Ann. Rheum. Dis. 2016;75 907.3-908.</Citation>
        </Reference>
        <Reference>
          <Citation>Dong C., Liu Y., Sun C., Liang H., Liu L. Identification of specific joint-inflammatogenic cell-free DNA molecules from synovial fluids of patients with rheumatoid arthritis. Front. Immunol. 2020;11:662.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7198838</ArticleId>
            <ArticleId IdType="pubmed">32411129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Daraghmeh D.N., King C., Wiese M.D. A review of liquid biopsy as a tool to assess epigenetic, cfDNA and miRNA variability as methotrexate response predictors in patients with rheumatoid arthritis. Pharmacol. Res. 2021;173</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34536550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mondelo-Macia P., Castro-Santos P., Castillo-Garcia A., Muinelo-Romay L., Diaz-Pena R. Circulating free DNA and its emerging role in autoimmune diseases. J. Personalized Med. 2021;11:1–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7924199</ArticleId>
            <ArticleId IdType="pubmed">33672659</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang H., Peng B., Dong C., Liu L., Mao J., Wei S., Wang X., Xu H., Shen J., Mao H.Q. Cationic nanoparticle as an inhibitor of cell-free DNA-induced inflammation. Nat. Commun. 2018;9:4291.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6191420</ArticleId>
            <ArticleId IdType="pubmed">30327464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chamilos G., Gregorio J., Meller S., Lande R., Kontoyiannis D.P., Modlin R.L., Gilliet M. Cytosolic sensing of extracellular self-DNA transported into monocytes by the antimicrobial peptide LL37. Blood. 2012;120:3699.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3488884</ArticleId>
            <ArticleId IdType="pubmed">22927244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tian J., Avalos A.M., Mao S.Y., Chen B., Senthil K., Wu H., Parroche P., Drabic S., Golenbock D., Sirois C. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 2007;8:487–496.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17417641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang H., Wang H., Andersson U. Targeting inflammation driven by HMGB1. Front. Immunol. 2020;11:484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7099994</ArticleId>
            <ArticleId IdType="pubmed">32265930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan Y., Liang H., Liu X., Liu L., Chen Y. Topical cationic hairy particles targeting cell free DNA in dermis enhance treatment of psoriasis. Biomaterials. 2021;276:121027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34293700</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Temburni S., Andersen R.M., Allen S.L., Barrientos J.C., Damle R.N. TLR-9 and B-cell antigen receptor triggering of primary B cells from mantle cell lymphoma induce cell proliferation and telomerase activity. Blood. 2011;118:3690.</Citation>
        </Reference>
        <Reference>
          <Citation>Svetlana K., Tatiana S., Larisa K., Lev P., Anatolij S., Elizaveta E., Sergey S., Vera I., Natalia V. GC-rich extracellular DNA induces oxidative stress, double-strand DNA breaks, and DNA damage response in human adipose-derived mesenchymal stem cells. Oxid. Med. Cell. Longev. 2015 2015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4529983</ArticleId>
            <ArticleId IdType="pubmed">26273425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodero M., Tesser A., Bartok E., Rice G., Mina E.D. Type I interferon-mediated autoinflammation due to DNase II deficiency. Nat. Commun. 2017;8:2176.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5736616</ArticleId>
            <ArticleId IdType="pubmed">29259162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pawaria S., Nündel K., Gao K., Moses S., Busto P., Holt K. Role of interferon‐γ–producing Th1 cells in a murine model of type I interferon–independent autoinflammation resulting from DNase II deficiency. Arthritis Rheumatol. 2020;72</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6994331</ArticleId>
            <ArticleId IdType="pubmed">31464028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kilpinen H., Waszak S., Gschwind A., Raghav S., Witwicki R. Coordinated effects of sequence variation on DNA binding, chromatin structure, and transcription. Science (New York, N.Y.) 2013;342:744–747.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5502466</ArticleId>
            <ArticleId IdType="pubmed">24136355</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>LaChelt U., Wagner E. Nucleic acid therapeutics using polyplexes: a journey of 50 Years (and beyond) Chem. Rev. 2015;115:11043–11078.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25872804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dawulieti J., Sun M., Zhao Y., Shao D., Yan H. Treatment of severe sepsis with nanoparticulate cell-free DNA scavengers. Adv. Sci. 2020;6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7259927</ArticleId>
            <ArticleId IdType="pubmed">32523983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yun Y.L., Park H.H., Park W., Kim H., Park C.G. Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm. Biomaterials. 2021;267</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7583619</ArticleId>
            <ArticleId IdType="pubmed">33130319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Q., Dehaini D., Zhang Y., Zhou J., Chen X., Zhang L., Fang R.H., Gao W., Zhang L. Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis. Nat. Nanotechnol. 2018;13:1182–1190.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30177807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X., Cao J., Li H., Li J., Jin Q., Ren K., Ji J. Mussel-Inspired polydopamine: a biocompatible and ultrastable coating for nanoparticles in vivo. ACS Nano. 2013;7:9384–9395.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24010584</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou T., Yan L., Xie C., Li P., Jiang L., Fang J., Zhao C., Ren F., Wang K., Wang Y., Zhang H., Guo T., Lu X. A mussel‐inspired persistent ROS‐scavenging, electroactive, and osteoinductive scaffold based on electrochemical‐driven in situ nanoassembly. Small. 2019;15</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31106983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bao X., Zhao J., Jian S., Hu M., Yang X. Polydopamine nanoparticles as efficient scavengers for reactive oxygen species in periodontal disease. ACS Nano. 2018;12:8882–8892.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30028940</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Long B.V., Sato Y., Chonpathompikunlert P., Tanasawet S., Nagasaki Y. Self-assembled polydopamine nanoparticles improve treatment in Parkinson's disease model mice and suppress dopamine-induced dyskinesia. Acta Biomater. 2020;109:220–228.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32268242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X., Zhao H., Liu Z., Wang Y., Shen S.G. Polydopamine nanoparticles as dual-task platform for osteoarthritis therapy: a scavenger for reactive oxygen species and regulator for cellular powerhouses. Chem. Eng. J. 2021;417</Citation>
        </Reference>
        <Reference>
          <Citation>Li J., Hou W., Lin S., Wang L., Pan C., Wu F., Liu J. Polydopamine nanoparticle-mediated dopaminergic immunoregulation in colitis. Adv. Sci. 2021</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8728836</ArticleId>
            <ArticleId IdType="pubmed">34713621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cha H.J., Dong S.H., Lim S. Development of bioadhesives from marine mussels. Biotechnol. J. 2008;3:631–638.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18293310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meng Y., Liu P., Zhou W., Ding J., Wen J. Bioorthogonal DNA adsorption on polydopamine nanoparticles mediated by metal coordination for highly robust sensing in serum and living cells. ACS Nano. 2018;12:9070–9080.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30130385</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Y., Ai K., Lu L. Polydopamine and its derivative materials: synthesis and promising applications in energy, environmental, and biomedical fields. Chem. Rev. 2014;114:5057–5115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24517847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu Z., Wu P., Liu G., He X., Qi B., Zeng G., Wang W., Sun Y., Cui F. Ultrahigh adsorption capacity of anionic dyes with sharp selectivity through the cationic charged hybrid nanofibrous membranes. Chem. Eng. J. 2016;313:957–966.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang Y., Ma X., Ding C., Jia L. pH-responsive deoxyribonucleic acid capture/release by polydopamine functionalized magnetic nanoparticles - ScienceDirect. Anal. Chim. Acta. 2015;862:33–40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25682426</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Priyam A., Nagar P., Sharma A.K., Kumar P. Mussel-inspired polydopamine-polyethylenimine conjugated nanoparticles as efficient gene delivery vectors for mammalian cells. Colloids Surf. B Biointerfaces. 2018;161:403–412.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29121613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zmerli I., Michel J.P., Makky A. Bioinspired polydopamine nanoparticles: synthesis, nanomechanical properties, and efficient PEGylation strategy. J. Mater. Chem. B. 2020;8:4489–4504.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32365146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pretorius E., Akeredolu O.O., Soma P., Kell D.B. Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability. Exp. Biol. Med. 2017;242:355–373.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5298544</ArticleId>
            <ArticleId IdType="pubmed">27889698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mark P., Sharareh A., Claudia Z.A. Cell-free DNA release by mouse placental explants. PLoS One. 2017;12</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5473530</ArticleId>
            <ArticleId IdType="pubmed">28622381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang J., Wang Y., Zhang H., Chang J., Yin Z. Identification of a novel microRNA-141-3p/Forkhead box C1/β-catenin axis associated with rheumatoid arthritis synovial fibroblast function in vivo and in vitro. Theranostics. 2020;10:5412–5434.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7196314</ArticleId>
            <ArticleId IdType="pubmed">32373221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu J., Liang H., Li Y., Shi Y., Bottini M., Chen Y., Liu L. Cationic block copolymer nanoparticles with tunable DNA affinity for treating rheumatoid arthritis. Adv. Funct. Mater. 2020;30</Citation>
        </Reference>
        <Reference>
          <Citation>Yan Y., Liang H., Liu X., Liu L., Chen Y. Topical cationic hairy particles targeting cell free DNA in dermis enhance treatment of psoriasis. Biomaterials. 2012;276:121027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34293700</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xue S., Zhou X., Sang W., Wang C., Lu H., Xu Y., Zhong Y., Zhu L., He C., Ma J. Cartilage-targeting peptide-modified dual-drug delivery nanoplatform with NIR laser response for osteoarthritis therapy. Bioact Mater. 2021;6:18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7844135</ArticleId>
            <ArticleId IdType="pubmed">33553822</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu J., Liang H., Li Y., Shi Y., Bottini M., Chen Y., Liu L. Cationic block copolymer nanoparticles with tunable DNA affinity for treating rheumatoid arthritis. Adv. Funct. Mater. 2020;30</Citation>
        </Reference>
        <Reference>
          <Citation>Ma C., Li B., Zhang J., Sun Y., Li J., Zhou H., Shen J., Gu R., Qian J., Fan C., Zhang H., Liu K. Significantly improving the bioefficacy for rheumatoid arthritis with supramolecular nanoformulations. Adv. Mater. 2021;33</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33733490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang H., Yan Y., Wu J., Ge X., Chen Y. Topical nanoparticles interfering with the DNA-LL37 complex to alleviate psoriatic inflammation in mice and monkeys. Sci. Adv. 2020;6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7457336</ArticleId>
            <ArticleId IdType="pubmed">32923608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang B., Yao H., Yang J., Chen C., Guo Y., Fu H., Shi J.  J Am Chem Soc; 2021. In Situ Synthesis of Natural Antioxidase Mimics for Catalytic Anti-inflammatory Treatments: Rheumatoid Arthritis as an Example.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34881869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsuchiya H., Ota M., Fujio K. Multiomics landscape of synovial fibroblasts in rheumatoid arthritis. Inflamm. Regen. 2021;41:7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7919303</ArticleId>
            <ArticleId IdType="pubmed">33641680</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsuchiya H., Ota M., Sumitomo S., Ishigaki K., Fujio K. Parsing multiomics landscape of activated synovial fibroblasts highlights drug targets linked to genetic risk of rheumatoid arthritis. Ann. Rheum. Dis. 2020;80 annrheumdis-2020-218189.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33139312</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim K.W., Kim B.M., Won J.Y., Min H.K., Lee K.A., Lee S.H., Kim H.R. Regulation of osteoclastogenesis by mast cell in rheumatoid arthritis. Arthritis Res. Ther. 2021;23:124.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8059019</ArticleId>
            <ArticleId IdType="pubmed">33882986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hyde S.C., Pringle I.A., Abdullah S., Lawton A.E., Davies L.A., Varathalingam A., Nunez-Alonso G., Green A.M., Bazzani R.P., Sumner-Jones S.G. CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression. Nat. Biotechnol. 2008;26:549–551.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18438402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee J., Jackman J.G., Kwun J., Manook M., Moreno A., Elster E.A., Kirk A., Leong K.W., Sullenger B.A. Nucleic acid scavenging microfiber mesh inhibits trauma-induced inflammation and thrombosis. Biomaterials. 2017;120:94–102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5260826</ArticleId>
            <ArticleId IdType="pubmed">28049065</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jing J., Ma J.D., Mo Y.Q., Chen L.F., Dai L. AB0216Overexpression of synovial lining peroxisome proliferator-activated receptor-gamma coactivator-1β involved in joint destruction through upregulating MMP-3 in rheumatoid arthritis. Ann. Rheum. Dis. 2016;75 971.2-972.</Citation>
        </Reference>
        <Reference>
          <Citation>Bajpayee A.G., Grodzinsky A.J. Cartilage-targeting drug delivery: can electrostatic interactions help? Nat. Rev. Rheumatol. 2017;13:183–193.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28202920</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Av A., Ekw A., Sm A., Th A., Cz A., Agba B. Cartilage penetrating cationic peptide carriers for applications in drug delivery to avascular negatively charged tissues. Acta Biomater. 2019;93:258–269.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6551323</ArticleId>
            <ArticleId IdType="pubmed">30529083</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
